These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23507258)

  • 1. Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trial.
    Büchler M; Longuet H; Lemoine R; Herr F; Gatault P; Thibault G; Ternant D; Foulon C; Pilorge B; Lemay D; Sung C; Halimi JM; Baron C; Lebranchu Y
    Transpl Immunol; 2013 Mar; 28(2-3):120-6. PubMed ID: 23507258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose rabbit antithymocyte globulin induction therapy results in prolonged selective lymphocyte depletion irrespective of maintenance immunosuppression.
    Pankewycz O; Leca N; Kohli R; Wallace PK; Said M; Feng L; Alnimri M; Patel S; Laftavi MR
    Transplant Proc; 2011 Mar; 43(2):462-5. PubMed ID: 21440734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allografts.
    Goh BK; Chedid MF; Gloor JM; Raghavaiah S; Stegall MD
    Transpl Immunol; 2012 Oct; 27(2-3):95-100. PubMed ID: 22813834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
    Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intraoperative versus postoperative administration of rabbit antithymocyte antibodies on 1-year renal function in renal transplant patients.
    Kamar N; Esposito L; Ribes D; Tkaczuk J; Cointault O; Lavayssiere L; Abbal M; Durand D; Rostaing L
    Exp Clin Transplant; 2006 Jun; 4(1):429-38. PubMed ID: 16827639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
    Eason JD; Loss GE; Blazek J; Nair S; Mason AL
    Liver Transpl; 2001 Aug; 7(8):693-7. PubMed ID: 11510013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM
    Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal.
    Tsapepas DS; Mohan S; Tanriover B; Dube G; Crew RJ; Cohen DJ; Hardy MA; Sandoval PR; Ratner LE
    Transplantation; 2012 Aug; 94(4):325-30. PubMed ID: 22814328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine.
    Kawaguchi A; Szentpetery S; Mohanakumar T; Barnhart GR; Lower RR
    J Heart Transplant; 1987; 6(4):214-7. PubMed ID: 3312532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.
    Trofe-Clark J; Reese PP; Patel HJ; Jakobowski D; Goral S; Doll SL; Abt PL; Bloom RD
    Transplantation; 2012 Sep; 94(5):506-12. PubMed ID: 22895613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras.
    Rogers CC; Asipenko N; Horwedel T; Gautam S; Goldfarb-Rumyantzev AS; Pavlakis M; Johnson SR; Karp SJ; Evenson A; Khwaja K; Hanto DW; Mandelbrot DA
    Am J Nephrol; 2013; 38(5):397-404. PubMed ID: 24192457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.
    Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; van Dam T; Ijzermans JN; Weimar W; Baan CC
    Transplantation; 2010 Mar; 89(6):655-66. PubMed ID: 20164820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients.
    Esposito L; Kamar N; Tkaczuk J; Abbal M; Durand D; Rostaing L
    Transplant Proc; 2005 Mar; 37(2):785-7. PubMed ID: 15848531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P; Cooper JE; Weiss AS; Gralla J; Owen P; Chan L; Wiseman AC
    Transplantation; 2009 Oct; 88(7):891-6. PubMed ID: 19935460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical outcome of low-dose and high-dose rabbit antithymocyte globulin induction therapy in renal transplantation: a single-center experience.
    Yang JW; Wang JN; Men TY; Zhang XM; Li XD; Shen B; Li GY; Chen DD
    Ann Transplant; 2014 Jun; 19():277-82. PubMed ID: 24906405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation.
    Ruggenenti P; Codreanu I; Cravedi P; Perna A; Gotti E; Remuzzi G
    Clin J Am Soc Nephrol; 2006 May; 1(3):546-54. PubMed ID: 17699258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of homeostatic proliferation and thymopoiesis after rATG induction therapy in kidney transplant patients.
    Bouvy AP; Kho MM; Klepper M; Litjens NH; Betjes MG; Weimar W; Baan CC
    Transplantation; 2013 Nov; 96(10):904-13. PubMed ID: 23985721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retreatment by antithymocyte globulin for second kidney transplantation: efficacy, tolerance and safety.
    Rodríguez-Reimundes E; Buron F; Chauvet C; Daoud S; Thaunat O; Brunet M; Badet L; Morelon E
    Transpl Immunol; 2013 Jan; 28(1):6-8. PubMed ID: 23220146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rabbit antithymocyte globulin in cardiac transplantation. Relationship of serum clearance rates to clinical outcome.
    Bieber CP; Griepp RB; Oyer PE; Wong J; Stinson EB
    Transplantation; 1976 Nov; 22(5):478-88. PubMed ID: 793103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.